Xiao-Jun Huang on cellular therapy in China

The Lancet Haematology in conversation with

English - November 28, 2022 23:00 - 28 minutes - 19.4 MB
Life Sciences Science Education blood haemophilia haematology leukaemia Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Glenn Pierce on haemophilia care in LMICs

Next Episode: Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes

Professor Xiao-Jun Huang discusses this Lancet Haematology series on Cellular Therapy in China, covering the history, current research challenges, and future of HSCT and CAR T-cell therapies in China.

Read the Series papers:
Cellular therapy in China

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv